ATROPIN EDO

Glavne informacije

  • Zaščiteno ime:
  • ATROPIN EDO 5 mg/ml kapljice za oko
  • Farmacevtska oblika:
  • kapljice za oko, raztopina
  • Pot uporabe:
  • Način uporabe nedoločen
  • Enote v paketu:
  • Škatla z 10 enoodmernimi enotami po 0,5 ml
  • Uporabi za:
  • ljudje
  • Vrsta medicine:
  • Alopatska drog

Dokumentov

Lokalizacija

  • Na voljo v:
  • ATROPIN EDO 5 mg/ml kapljice za oko
    Slovenija
  • Jezik:
  • slovenščina

Terapevtski podatki

  • Terapevtska skupina:
  • atropin

Drugi podatki

Stanje

  • Source:
  • JAZMP - Javna agencija RS za zdravila in medicinske pripomočke - Slovenia Medicines Agency
  • Status dovoljenje:
  • Zdravilo z začasnim dovoljenjem za vnos/uvoz s seznama EZ ali NP
  • Datum dovoljenje:
  • 03-02-2016
  • Zadnja posodobitev:
  • 19-01-2018

16-11-2018

FDA approves first-line treatment for peripheral T-cell lymphoma under new review pilot

FDA approves first-line treatment for peripheral T-cell lymphoma under new review pilot

The FDA expanded the approved use of Adcetris (brentuximab vedotin) injection in combination with chemotherapy for adult patients with certain types of peripheral T-cell lymphoma (PTCL). This is the first FDA approval for treatment of newly diagnosed PTCL, and the agency used a new review program to complete the approval more quickly.

FDA - U.S. Food and Drug Administration

28-9-2018

Minister Fakin ob robu GS ZN predsedoval stranskemu dogodku o škodljivosti alkohola

Minister Fakin ob robu GS ZN predsedoval stranskemu dogodku o škodljivosti alkohola

Slovenija je v okviru 73. zasedanja Združenih narodov in 3. visokega zasedanja o kroničnih...

Ministrstvo za zdravje

29-8-2018

Risk to human and animal health related to the presence of 4,15‐diacetoxyscirpenol in food and feed

Risk to human and animal health related to the presence of 4,15‐diacetoxyscirpenol in food and feed

Published on: Thu, 16 Aug 2018 00:00:00 +0200 4,15‐Diacetoxyscirpenol (DAS) is a mycotoxin primarily produced by Fusarium fungi and occurring predominantly in cereal grains. As requested by the European Commission, the EFSA Panel on Contaminants in the Food Chain (CONTAM) assessed the risk of DAS to human and animal health related to its presence in food and feed. Very limited information was available on toxicity and on toxicokinetics in experimental and farm animals. Due to the limitations in the avai...

Europe - EFSA - European Food Safety Authority Publications

25-7-2018

Opinion/decision on a Paediatric investigation plan (PIP):    -, Enfortumab vedotin, Therapeutic area: Oncology

Opinion/decision on a Paediatric investigation plan (PIP): -, Enfortumab vedotin, Therapeutic area: Oncology

Europe - EFSA - European Food Safety Authority EFSA Journal

28-6-2018

June 28, 2018: Southern District of Florida Charges 124 Individuals Responsible for $337 Million in False Billing as Part of National Healthcare Fraud Takedown

June 28, 2018: Southern District of Florida Charges 124 Individuals Responsible for $337 Million in False Billing as Part of National Healthcare Fraud Takedown

June 28, 2018: Southern District of Florida Charges 124 Individuals Responsible for $337 Million in False Billing as Part of National Healthcare Fraud Takedown

FDA - U.S. Food and Drug Administration

6-6-2018

Vabilo na 3/2018 sejo Zdravstvenega sveta

Vabilo na 3/2018 sejo Zdravstvenega sveta

Vljudno vabljeni na 3/2018 sejo Zdravstvenega sveta, ki bo v sredo, 6. junija 2018, ob 15. uri v...

Ministrstvo za zdravje

25-5-2018

Dough-To-Go Issues Allergy Alert on Undeclared Tree Nuts in Zoe’s Vegan Tuxedo Fudge Cookie

Dough-To-Go Issues Allergy Alert on Undeclared Tree Nuts in Zoe’s Vegan Tuxedo Fudge Cookie

Dough-to-Go of Santa Clara, CA is recalling 20 cases of cookies because they may contain undeclared tree nuts. People who have an allergy or severe sensitivity to walnuts run the risk of serious or life-threatening allergic reaction if they consume this product.

FDA - U.S. Food and Drug Administration

9-5-2018

Vabilo na 2/2018 sejo Zdravstvenega sveta

Vabilo na 2/2018 sejo Zdravstvenega sveta

Spoštovani,  vabimo vas na 2/2018 sejo Zdravstvenega sveta, ki bo v sredo, 9. maja 2018, ob 15....

Ministrstvo za zdravje

12-4-2018

Ministrica za zdravje se je udeležila proslave ob 70-letnici SB Jesenice

Ministrica za zdravje se je udeležila proslave ob 70-letnici SB Jesenice

Ministrica za zdravje se je v sredo, 11. 4. 2018, udeležila proslave ob 70.letnivi SB Jesenice. Ob...

Ministrstvo za zdravje

7-3-2018

Vabilo na 1/2018 sejo Zdravstvenega sveta

Vabilo na 1/2018 sejo Zdravstvenega sveta

Spoštovani, vljubno vabljeni na 1/2018 sejo Zdravstvenega sveta, ki bo v sredo, 7. marca 2018, ob...

Ministrstvo za zdravje

6-12-2017

9/2017 seja Zdravstvenega sveta

9/2017 seja Zdravstvenega sveta

Spoštovani, vljudno vabljeni na 9/2017 sejo Zdravstvenega sveta, ki bo v sredo, 6.decembra 2017,...

Ministrstvo za zdravje

12-9-2018

ADCETRIS (Takeda Pharma A/S)

ADCETRIS (Takeda Pharma A/S)

ADCETRIS (Active substance: Brentuximab vedotin) - Centralised - Annual renewal - Commission Decision (2018)5973 of Wed, 12 Sep 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/2455/R/58

Europe -DG Health and Food Safety

27-8-2018

Entyvio (Takeda Pharma A/S)

Entyvio (Takeda Pharma A/S)

Entyvio (Active substance: vedolizumab) - PSUSA - Modification - Commission Decision (2018)5712 of Mon, 27 Aug 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/PSUSA/10186/201711

Europe -DG Health and Food Safety

27-7-2018

EU/3/18/2013 (Roche Registration GmbH)

EU/3/18/2013 (Roche Registration GmbH)

EU/3/18/2013 (Active substance: Polatuzumab vedotin) - Transfer of orphan designation - Commission Decision (2018)5054 of Fri, 27 Jul 2018 European Medicines Agency (EMA) procedure number: EMA/OD/231/17/T/01

Europe -DG Health and Food Safety

29-6-2018

EU/3/18/2035 (Hanmi Europe Limited)

EU/3/18/2035 (Hanmi Europe Limited)

EU/3/18/2035 (Active substance: Efpegsomatropin) - Orphan designation - Commission Decision (2018)4180 of Fri, 29 Jun 2018 European Medicines Agency (EMA) procedure number: EMA/OD/009/18

Europe -DG Health and Food Safety

18-4-2018

EU/3/18/2013 (Roche Registration Limited)

EU/3/18/2013 (Roche Registration Limited)

EU/3/18/2013 (Active substance: Polatuzumab vedotin) - Orphan designation - Commission Decision (2018)2409 of Wed, 18 Apr 2018 European Medicines Agency (EMA) procedure number: EMA/OD/231/17

Europe -DG Health and Food Safety

6-3-2018

Somatropin

Somatropin

Somatropin (Active substance: somatropin) - Centralised - Art 28 - (PSUR - Commission Decision (2018) 1479 of Tue, 06 Mar 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/PSUSA/2772/201703

Europe -DG Health and Food Safety